163
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Tracking retention and transport of ultrafine polystyrene in an asthmatic mouse model using positron emission tomography

, , , &
Pages 304-313 | Received 11 Apr 2013, Accepted 20 Jun 2013, Published online: 06 Aug 2013

REFERENCES

  • Braman SS: The global burden of asthma. Chest. 2006;130(1):4S–12S.
  • Hamid Q, Tulic M, Liu M, Moqbel R: Inflammatory cells in asthma: mechanisms and implications for therapy. J Allergy Clin Immunol. 2003;111:S5–S17.
  • (WHO) WHO: Prevention of allergy and allergic asthma. World Health Organization. 2002:1–14.
  • Pope C. Epidemiology of fine particulate air pollution and human health: biologic mechanisms and who's at risk?. Environ Health Perspect. 2000;108:713–723.
  • Atkinson RW, Anderson HR, Sunyer J, Ayres J, Baccini M, Vonk JM, Boumghar A, Forastiere F, Forsberg B, Touloumi G, Schwartz J, Katsouyanni K: Acute effects of particulate air pollution on respiratory admissions - results from APHEA 2 project. Am J Respir Crit Care Med. 2001;164(10):1860–1866.
  • Burnett RT, Dales R, Krewski D, Vincent R, Dann T, Brook JR: Associations between ambient particulate sulfate and admissions to ontario hospitals for cardiac and respiratory diseases. Am J Epidemiol. 1995;142(1):15–22.
  • Lin M, Chen Y, Burnett RT, Villeneuve PJ, Krewski D: The influence of ambient coarse particulate matter on asthma hospitalization in children: Case-crossover and time-series analyses. Environ Health Perspect 2002;110(6):575–581.
  • Peters A, Dockery D, Heinrich J, Wichmann H: Short-term effects of particulate air pollution on respiratory morbidity in asthmatic children. Eur Respir J. 1997;10(4):872–879.
  • Koenig JQ, Larson TV, Hanley QS, Rebolledo V, Dumler K, Checkoway H, Wang SZ, Lin DY, Pierson WE: Pulmonary-function changes in children associated with fine particulate matter. Environ Res. 1993;63(1):26–38.
  • Pope CA, III, Bates DV, Raizenne ME: Health Effects of Particulate Air Pollution: Time for Reassessment? Environ Health Perspect. 1995;103(5):472–480.
  • Gong H, Linn WS, Clark KW, Anderson KR, Sioutas C, Alexis NE, Cascio WE, Devlin RB: Exposures of healthy and asthmatic volunteers to concentrated ambient ultrafine particles in Los Angeles. Inhal Toxicol. 2008;20(6):533–545.
  • Gong H, Linn WS, Terrell SL, Clark KW, Geller MD, Anderson KR, Cascio WE, Sioutas C: Altered heart-rate variability in asthmatic and healthy volunteers exposed to concentrated ambient coarse particles. Inhal Toxicol. 2004;16(6–7):335–343.
  • Brown JS, Zeman KL, Bennett WD: Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am J Respir Crit Care Med. 2002;166(9):1240–1247.
  • Kreyling WG, Semmler M, Erbe F, Mayer P, Takenaka S, Schulz H, Oberdorster G, Ziesenis A: Translocation of ultrafine insoluble iridium particles from lung epithelium to extrapulmonary organs is size dependent but very low. J Toxicol Environ Health A. 2002;65(20):1513–1530.
  • Nemmar A, Hoet PHM, Vanquickenborne B, Dinsdale D, Thomeer M, Hoylaerts MF, Vanbilloen H, Mortelmans L, Nemery B; Passage of inhaled particles into the blood circulation in humans. Circulation. 2002;105(4):411–414.
  • Semmler M, Seitz J, Erbe F, Mayer P, Heyder J, Oberdorster G, Kreyling WG: Long-term clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung, including transient translocation into secondary organs. Inhal Toxicol 2004 Jun;16(6–7):453–459.
  • Alessandrini F, Semmler-Behnke M, Jakob T, Schulz H, Behrendt H, Kreyling W: Total and regional deposition of ultrafine particles in a mouse model of allergic inflammation of the lung. Inhal Toxicol. 2008;20(6):585–593.
  • Chalupa D, Morrow P, Oberdorster G, Utell M, Frampton M: Ultrafine particle deposition in subjects with asthma. Environ Health Perspect. 2004;112:879–882.
  • Oberdorster G, Ferin J, Finkelstein G, Wade P, Corson N: Increased Pulmonary Toxicity of Ultrafine Particles .2. Lung Lavage Studies. J Aerosol Sci. 1990;21(3):384–387.
  • Oberdorster G, Ferin J, Soderholm S, Gelein R, Cox C, Baggs R, Morrow PE: Increased pulmonary toxicity of inhaled ultrafine particles: due to lung overload alone? Ann Occup Hyg. 1994;38(inhaled_particles_VII):295–302.
  • Wiebert P, Sanchez-Crespo A, Falk R, Philipson K, Lundin A, Larsson S, Moller W, Kreyling WG, Svartengren M: No significant translocation of inhaled 35-nm carbon particles to the circulation in humans. Inhal Toxicol 2006;18(10):741–747.
  • Wiebert P, Sanchez-Crespo A, Seitz J, Falk R, Philipson K, Kreyling WG, Moller W, Sommerer K, Larsson S, Svartengren M: Negligible clearance of ultrafine particles retained in healthy and affected human lungs. Eur Respir J. 2006;28(2):286–290.
  • Petersson J, S√°nchez-Crespo A, Larsson SA, Mure M: Physiological imaging of the lung: single-photon-emission computed tomography (SPECT). J Appl Physiol. 2007;102(1):468–476.
  • Palko HA, Fung JY, Louie AY: Positron emission tomography: a novel technique for investigating the biodistribution and transport of nanoparticles. Inhal Toxicol. 2010;22(8):657– 688.
  • Oberdorster G: Lung clearance of inhaled insoluble and soluble particles. J Aerosol Med. 1988;1(4):289–330.
  • Kenyon NJ, Last JA: Reversible and irreversible airway inflammation and fibrosis in mice exposed to inhaled ovalbumin. Inflamm Res. 2005;54(2):57–65.
  • Lim Y, Vasu VT, Valacchi G, Leonard S, Aung HH, Schock BC, Kenyon NJ, Li C-S, Traber MG, Cross CE: Severe Vitamin E deficiency modulates airway allergic inflammatory responses in the murine asthma model. Free Radic Res. 2008;42(4):387–396.
  • Kim JS, Lee JS, Im KC, Kim SJ, Kim SY, Lee DS, Moon DH: Performance measurement of the microPET focus 120 scanner. J Nucl Med. 2007;48(9):1527–1535.
  • Illum L, Davis SS: Targeting of colloidal particles to the bone marrow. Life Sci. 1987;40(16):1553–1560.
  • David E, Bice JS, Francis H. Y., Green: Animal models of asthma: potential usefulness for studying health effects of inhaled particles. Inhal Toxicol. 2000;12(9):829– 862.
  • Lehnert BE: Pulmonary and thoracic macrophage subpopulations and clearance of particles from the lung. Environ Health Perspect 1992;97:17–46.
  • Ferin J: Pulmonary retention and clearance of particles. Toxicol Lett. 1994;72(1–3):121–125.
  • Harmsen AG, Muggenburg BA, Snipes MB, Bice DE: The role of macrophages in particle translocation from lungs to lymph-nodes. Science. 1985;230(4731):1277–1280.
  • Lippmann M, Yeates DB, Albert RE: Deposition, retention, and clearance of inhaled particles. Br J Ind Med. [Review]. 1980;37(4):337–362.
  • Corry D, Kulkarni P, Lipscomb MF: The migration of bronchoalveolar macrophages into hilar lymph-nodes. Am J Pathol. 1984;115(3):321–328.
  • Kenyon NJ, Ward RW, Last JA: Airway fibrosis in a mouse model of airway inflammation. Toxicol Appl Pharmacol 2003;186(2):90–100.
  • Bates JHT, Irvin CG: Measuring lung function in mice: the phenotyping uncertainty principle. J Appl Physiol 2003;94(4):1297–1306.
  • Bushberg JT, Seibert JA, Leidholdt EM, Boone JM: The Essential Physics of Medical Imaging. 2nd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2002.
  • Cherry SR: Physics in Nuclear Medicine. 3rd ed. Philadelphia, PA: Saunders; 2003.
  • Osier M, Oberdorster G: Intratracheal inhalation vs intratracheal instillation: differences in particle effects. Fundam Appl Toxicol. 1997;40(2):220–227.
  • Driscoll KE, Costa DL, Hatch G, Henderson R, Oberdorster G, Salem H, Schlesinger RB: Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations. Toxicol Sci. 2000;55(1):24–35.
  • Brain JD, Knudson DE, Sorokin SP, Davis MA: Pulmonary distribution of particles given by intratracheal instillation or by aerosol Inhalation. Environ Res. 1976;11(1):13–33.
  • Tronde A, Baran G, Eirefelt S, Lennernas H, Bengtsson UH: Miniaturized nebulization catheters: a new approach for delivery of defined aerosol doses to the rat lung. J Aerosol Med-Depos Clear Eff Lung. 2002 Fal;15(3):283–296.
  • Oberdorster G, Cox C, Gelein R: Intratracheal instillation versus intratracheal inhalation of tracer particles for measuring lung clearance function. Exp Lung Res 1997;23(1):17–34.
  • Ghio AJ, Devlin RB: Inflammatory lung injury after bronchial instillation of air pollution particles. Am J Respir Crit Care Med. 2001;164(4):704–8.
  • Bagate K, Meiring JJ, Gerlofs-Nijland ME, Vincent R, Cassee FR, Borm PJA: Vascular effects of ambient particulate matter instillation in spontaneous hypertensive rats. Toxicol Appl Pharmacol. [doi: DOI: 10.1016/j.taap.2004.02.005]. 2004;197(1):29–39.
  • Nemmar A, Vanbilloen H, Hoylaerts MF, Hoet PHM, Verbruggen A, Nemery B: Passage of intratracheally instilled ultrafine particles from the lung into the systemic circulation in hamster. Am J Respir Crit Care Med. 2001;164(9):1665– 1668.
  • Furuyama A, Kanno S, Kobayashi T, Hirano S: Extrapulmonary translocation of intratracheally instilled fine and ultrafine particles via direct and alveolar macrophage-associated routes. Arch Toxicol. 2009;83(5):429–437.
  • Delgado R, Felix V, Lima LMP, Price DW: Metal complexes of cyclen and cyclam derivatives useful for medical applications: a discussion based on thermodynamic stability constants and structural data. Dalton Trans. 2007(26):2734–2745.
  • Raos N, Milifçevifá A: Prediction of stability constants of coordination compounds from their molecular graphs. J Phys: Conf Ser. 2013;410(1):1–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.